Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D003429:Cross Reactions; D008168:Lung / Q000032:analysis* / Q000276:immunology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D010455:Peptides / Q000276:immunology / Q000302:isolation & purification* / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D013373:Substance P / Q000494:pharmacology; D013552:Swine; D014660:Vasoactive Intestinal Peptide / Q000276:immunology; D014665:Vasodilator Agents / Q000302:isolation & purification*
D010455:Peptides; D011453:Prostaglandins; D014665:Vasodilator Agents; D000804:Angiotensin II; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D001920:Bradykinin